Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vedolizumab subcutaneous maintenance therapy in Crohn's disease after intravenous induction
jRCT2080223331Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Vedolizumab SC maintenance with Placebo SC maintenance (2 arms). Started Sep 2016; status: completed.
02
Drugs
vedolizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080223331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223331.